Our results provide a structural platform to guide development of anti-tuberculosis antimicrobials based on Fdx.
Introduction
The bacterial RNA polymerase (RNAP) is a proven target for antibiotics. The rifamycin (Rif) class of antibiotics, which inhibit RNAP function, is a lynchpin of modern tuberculosis (TB) treatment (Chakraborty and Rhee, 2015) . TB, caused by the infectious agent Mycobacterium tuberculosis (Mtb), is responsible for almost 2 million deaths a year. It is estimated that one third of the world is infected. Mortality from TB is increasing, partly due to the emergence of strains resistant to Rifs (Rif R ) (Salinas et al., 2016) . Hence, additional antibiotics against Rif R Mtb are needed.
Fidaxomicin (Fdx; also known as Dificimicin, lipiarmycin, OPT-80, PAR-101, or tiacumicin), an antimicrobial in clinical use against Clostridium difficile (Cdf) infection (Venugopal and Johnson, 2012) , functions by inhibiting the bacterial RNAP (Talpaert et al., 1975) . Fdx targets the RNAP 'switch region', a determinant for RNAP inhibition that is distinct from the Rif binding pocket (Srivastava et al., 2011) , and Fdx does not exhibit cross-resistance with Rif (Gualtieri et al., 2009; Kurabachew et al., 2008; O'Neill et al., 2000) . The switch region sits at the base of the mobile RNAP clamp domain and, like a hinge, controls motions of the clamp crucial for DNA loading into the RNAP activesite cleft and maintaining the melted DNA in the channel (Chakraborty et al., 2012; Feklistov et al., 2017) . Fdx is a narrow spectrum antibiotic that inhibits Gram-positive anaerobes and mycobacteria (including Mtb) much more potently than Gram-negative bacteria (Kurabachew et al., 2008; Srivastava et al., 2011) , but the clinical use of Fdx is limited to intestinal infections due to poor bioavailability (Venugopal and Johnson, 2012) . Modifying Fdx to address this limitation requires understanding the structural and mechanistic basis for Fdx inhibition, which is heretofore unknown. Here, we used singleparticle cryo-electron microscopy (cryo-EM) to determine structures of Mtb transcription initiation complexes in three distinct conformational states, including a complex with Fdx at an overall resolution of 3.4 Å. The results define the molecular interactions of
Mtb RNAP with Fdx as well as the mechanistic basis of inhibition, and establish that
RbpA, an Actinobacteria-specific general transcription factor (GTF), is crucial to the sensitivity of Mtb to Fdx.
Results

Fdx potently inhibits mycobacterial TICs in vitro
Fdx has potent inhibitory activity against multi-drug-resistant Mtb cells and the in vivo target is the RNAP (Kurabachew et al., 2008) . To our knowledge, the in vitro activity of Fdx against mycobacterial RNAPs have not been reported. RbpA, essential in Mtb, is a component of transcription initiation complexes (TICs) that tightly binds the primary promoter specificity s A subunit of the RNAP holoenzyme (holo) (Bortoluzzi et al., 2013; Forti et al., 2011; Hubin et al., 2017a; Tabib-Salazar et al., 2013 Cryo-EM structure of the Fdx/RbpA/s A -holo complex We used single-particle cryo-EM to examine the complex of Mtb RbpA/s A -holo with and without Fdx ( Figure 1B ). Preliminary analyses revealed that the particles were prone to oligomerization, which was reduced upon addition of an upstream-fork (us-fork) junction promoter DNA fragment ( Figure 1C ). We sorted nearly 600,000-cryo-EM images of Figure 1D ). Local resolution calculations (Cardone et al., 2013) indicated that the central core of the structure, including the Fdx binding determinant and the bound Fdx, was determined to 2.9 -3.4 Å resolution ( Figure 1E ).
Cryo-EM structure of a Mtb RPo mimic
The second class comprised Mtb RbpA/s A -holo bound to two us-fork promoter fragments but without Fdx to a nominal resolution of 3.3 Å ( Figure 1C ) engaged with the RNAP active site (as the template strand) like previously characterized 3'-tailed templates (Gnatt et al., 2001; Kadesch and Chamberlin, 1982) . Local resolution calculations (Cardone et al., 2013) indicated that the central core of the structure was determined to between 2.8 -3.2 Å resolution ( Figure 2B ). The overall conformation of this protein complex and its engagement with the upstream and downstream DNA fragments was very similar to the crystal structure of a full Msm open promoter complex (RPo) (Hubin et al., 2017b) with one exception (see below). We will therefore call this complex an Mtb RbpA/RPo mimic.
The RbpA N-terminal tail invades the RNAP active site cleft
RbpA comprises four structural elements, the N-terminal tail (NTT), the core domain (CD), the basic linker, and the sigma interacting domain (SID) (Bortoluzzi et al., 2013; Hubin et al., 2017a; Tabib-Salazar et al., 2013 (Hubin et al., 2017a; 2017b) . Density for the RbpA NTT (RbpA residues 1-25) was never observed in the crystal structures and was presumed to be disordered. In striking contrast to the crystal structures, both cryo-EM structures reveal density for the RbpA NTT , which unexpectedly threads into the RNAP active site cleft between the ZBD and s A 4 domains, snakes through a narrow channel towards the RNAP active site Mg 2+ ( Figure 3 ). On its path, conserved residues of the RbpA NTT interact with conserved residues of the s-finger (s 3.2 -linker) on one wall of the channel, and with conserved residues of the ZBD and b'lid on the other wall ( Figure 3C ).
The most N-terminal RbpA residues visible in the cryo-EM structures (A2 in the Fdx complex, R4 in the RPo) sit near the tip of the s-finger where it makes its closest approach to the RNAP active site, too far (25 Å) to play a direct role in RNAP catalytic activity or substrate binding. The s-finger plays an indirect role in transcription initiation, stimulating de novo phosphodiester bond formation by helping to position the t-strand DNA (Kulbachinskiy and Mustaev, 2006; Zhang et al., 2012) . The s-finger is also a major determinant of abortive initiation, playing a direct role in initiation and promoter escape by physically blocking the path of the elongating RNA transcript before s release (Cashel et al., 2003; Murakami et al., 2002) . The intimate association of the RbpA NTT with the s-finger ( Figure 3C ) suggests that the RbpA NTT also plays a role in these processes of Mtb RNAP initiation. This is consistent with our findings that the RbpA NTT does not strongly affect RPo formation but plays a significant role in in vivo gene expression in Msm (Hubin et al., 2017a) . This location of the RbpA NTT explains the high Fdx sensitivity of Mtb RNAP (see below).
Fdx interacts with RNAP, s A , and RbpA
The reconstruction from the Fdx-bound class ( Figure 1D ) reveals unambiguous density for Fdx ( Figure 4A ) and defines Fdx-interacting residues from four protein components subunits from Bacillus subtilis (Gualtieri et al., 2006) , Cdf (Kuehne et al., 2017) , 
Fdx traps an open-clamp conformation
The RNAP switch regions are thought to act as hinges connecting the mobile clamp domain to the rest of the RNAP (Gnatt et al., 2001; Lane and Darst, 2010) . Bacterial RNAP inhibitors myxopyronin, corallopyronin, and ripostatin bind Sw1 and Sw2 and stabilize a closed-clamp conformation of the RNAP (Belogurov et al., 2008; Mukhopadhyay et al., 2008 Figure 5B). Because this complex is not interacting with any other ligands that might be expected to alter the clamp conformation (such as Fdx or DNA), we will refer to this as the 'relaxed' clamp conformation. The two Fdx-bound complexes, with or without usfork DNA, show further opening of the clamp (14° and 15°, respectively; orange and red in Figure 5B ).
Fdx acts like a doorstop to stabilize the open-clamp conformation
In the high-resolution Fdx/TIC structure ( Figure 1D 
Discussion
Fdx inhibits RNAP by trapping an open-clamp conformation
Clamp dynamics play multiple important roles in the transcription cycle. Motions of the clamp module and the role of the switch regions as hinges were first noted by comparing crystal structures of free RNAPs Zhang et al., 1999) with the crystal structure of an elongation complex containing template DNA and RNA transcript (Gnatt et al., 2001) . Binding of the downstream duplex DNA and RNA/DNA hybrid in the RNAP active-site cleft was proposed to close the clamp around the nucleic acids, explaining the high processivity of the transcription elongation complex.
Numerous subsequent crystal structures have supported the idea that stable, transcription-competent complexes of RNAP with nucleic acids, either RPo (Bae et al., 2015; Hubin et al., 2017b; Zuo and Steitz, 2015) or elongation complexes (Gnatt et al., 2001; Kettenberger et al., 2004; Vassylyev et al., 2007) , correlate with the closed-clamp conformation. Effects of crystal packing forces on clamp conformation, however, cannot always be ruled out. Observations of clamp positions by solution FRET (Chakraborty et al., 2012) , and more recently in cryo-EM structures (Bernecky et al., 2016; Hoffmann et al., 2015; Kang et al., 2017; Neyer et al., 2016) (in the absence of crystal packing forces) have confirmed the relationship between clamp closure and stable nucleic-acid complexes. Clamp motions have also been shown to play a critical role in the process of promoter melting to form the transcription bubble during RPo formation (Feklistov et al., 2017) . Thus, the trapping of an open-clamp RNAP conformation by Fdx in unrestrained cryo-EM conditions ( Figure 5C ) suggests that Fdx inhibits transcription initiation by preventing clamp motions required for RPo formation, or by not allowing RNAP to form stable transcription-competent complexes with nucleic acids, or both ( Figures 5C, D) .
Summary
Our results establish the molecular details of Fdx interactions with the bacterial RNAP ( Figures 4A, B) and a mechanism of action for Fdx ( Figures 5C, D) . Crucially, the essential actinobacterial GTF RbpA is responsible for the high sensitivity of Mtb RNAP to Fdx both in vitro ( Figure 4C ) and in vivo ( Figure 4D ). This new knowledge provides a structural platform for the development of antimicrobials based on Fdx and underscores the need to define structure-activity relationships of drug leads using near-native states, in this case using cryo-EM with the RbpA/s A -holo complex to guide development of effective Mtb treatments.
Materials and Methods
Protein Expression and Purification
Mtb RNAP overexpression plasmid. The overexpression plasmid (OEP) for Mtb RNAP was engineered from an existing OEP for M. bovis RNAP (Czyz et al., 2014) , pAC22
(Supplementary file 3). Four modifications were made. First, a sequence in pAC22 that encodes an N-terminal 6-aa insertion at codon 2 of rpoB was removed. Second, a sequence upstream of rpoZ that included an ATG that potentially allowed an N-terminal extension on w was removed. Third, to increase protein expression, the ribosomebinding sites (RBSs) for rpoA, rpoZ, and rpoB::C were re-engineered to encode stronger predicted RBSs using predicted translation initiation rates calculated using the Salis RBS strength calculator (https://salislab.net/software/) (Espah Borujeni et al., 2014 Samples for Cryo-EM particle preparation used Mtb His-tagged-σ A and RbpA coexpressed and purified as previously described (Hubin et al., 2015; 2017a) . To compare Fdx sensitivity of full-length RbpA and RbpA DNTT , these proteins, and Mtb His-tagged-σ A were expressed separately and purified as described previously (Hubin et al., 2015; 2017a) . Briefly, Rosetta-2 cells were co-transformed with pET plasmids expressing Mtb σ A (His-tagged) and RbpA and induced with 0.5 mM IPTG at 30°C for 4 hours. Clarified lysates was subjected to Ni 2+ affinity, removal of the His-tag, a second Ni 2+ affinity (collecting the flow through this time) and size exclusion chromatography.
Mtb RNAP was expressed and purified as previously described for Mbo and Msm
RNAPs (Davis et al., 2015; Hubin et al., 2017a) . Eco core RNAP, Eco σ 70 , Msm σ A ,
Msm RbpA, and Msm core RNAP were expressed and purified as described (Davis et al., 2015; Hubin et al., 2015; 2017a) (Davis et al., 2015; Hubin et al., 2015; Hubin et al., 2017) .
In vitro Transcription Assays
In vitro abortive initiation transcription assays were performed using the WT AP3 (-87 to +71) promoter at 37°C as described (Davis et al., 2015) polyacrylamide gel electrophoresis using phosphorimagery and quantified using Image J (Schneider et al., 2012) .
Agar disk diffusion assay
Msm strains MGM6232 (ΔrbpA attB::rbpA kan) and MGM6234 (ΔrbpA attB::rbpA(28-114) kan) (Hubin et al., 2017a) were grown overnight in LBsmeg (LB with 0.5% glycerol, 0.5% dextrose and 0.05% Tween 80 ) and 2 mL were centrifuged and resuspended in 200 µL of residual media and then plated. Filter discs were placed on the plates and stock solutions of Fdx were prepared in 10% DMSO at different concentrations (50 µM, 100 µM, 250 µM and 500 µM). 10 µl of antibiotic from each stock solution was pipetted onto the disks. Streptomycin (0.5 mg/ml, 860 µM) and 10% DMSO were used as positive and negative controls, respectively. Plates were incubated at 37 °C for 74 hours and the zone of inhibition around each disk was photographed and measured.
Preparation of Fdx/RbpA/σ A -holo Complexes for Cryo-EM
Mtb RbpA/σ A -holo (0.5 ml of 5 mg/ml) was injected into a Superose6 Increase column (GE Healthcare) equilibrated with 20 mM Tris-HCl pH 8.0, 150 mM K-Glutamate, 5 mM MgCl 2 , 2.5 mM DTT. The peak fractions of the eluted protein were concentrated by centrifugal filtration (Millipore) to 6 mg/mL protein concentration. Fdx (when used) was added at 100 µM and us-fork DNA (when used) was added to 20 µM. The samples were incubated on ice for 15 min and then 3-([3-cholamidopropyl]dimethylammonio)-2-hydroxy-1-propanesulfonate (CHAPSO) was added to the sample for a final concentration of 8 mM prior to grid preparation.
Cryo-EM grid preparation
C-flat CAu-1.2/1.3 400 mesh gold grids were glow-discharged for 20 s prior to the application of 3.5 µl of the sample (4.0-6.0 mg/ml protein concentration). After blotting for 3-4.5 s, the grids were plunge-frozen in liquid ethane using an FEI Vitrobot Mark IV (FEI, Hillsboro, OR) with 100% chamber humidity at 22 °C.
Cryo-EM data acquisition and processing
Fdx/RbpA/σ A -holo/us-fork. The grids were imaged using a 300 keV Titan Krios (FEI) equipped with a K2 Summit direct electron detector (Gatan). Images were recorded with Leginon (Nicholson et al., 2010) in counting mode with a pixel size of 1.1 Å and a defocus range of 0.8 μm to 1.8 μm. Data were collected with a dose of 8 electrons/px/s.
Images were recorded over a 10 second exposure with 0.2 second frames (50 total frames) to give a total dose of 66 electrons/Å 2 . Dose-fractionated subframes were aligned and summed using MotionCor2 (Zheng et al., 2017) and subsequent doseweighting was applied to each image. The contrast transfer function was estimated for each summed image using Gctf (Zhang, 2016) . From the summed images, Gautomatch (developed by K. Zhang, MRC Laboratory of Molecular Biology, Cambridge, UK, http://www.mrc-lmb.cam.ac.uk/kzhang/Gautomatch) was used to pick particles with an auto-generated template. Autopicked particles were manually inspected, then subjected to 2D classification in cryoSPARC (Davis et al., 2015) specifying 50 classes. Poorly populated and dimer classes were removed, resulting in a dataset of 582,169 particles.
A subset of the dataset was used to generate an initial model of the complex in cryoSPARC (ab-initio reconstruction). Using the ab-initio model (low-pass filtered to 30 Å-resolution), particles were 3D classified into two classes using cryoSPARC heterogenous refinement. CryoSPARC homogenous refinement was performed for each class using the class map and corresponding particles, yielding two structures with different clamp conformations: open (Fdx/RbpA/σ A -holo/us-fork; Figure 1D ) and closed collected with a dose of 8 electrons/px/s. Images were recorded over a 15 second exposure using 0.3 second subframes (50 total frames) to give a total dose of 53 electrons/Å 2 . Dose-fractionated subframes were 2 x 2 binned (giving a pixel size of 1.5 Å), aligned and summed using Unblur (Grant and Grigorieff, 2015) . The contrast transfer function was estimated for each summed image using Gctf (Zhang, 2016) .
From the summed images, Gautomatch (developed by K. Zhang, MRC Laboratory of Molecular Biology, Cambridge, UK, http://www.mrc-lmb.cam.ac.uk/kzhang/Gautomatch) was used to pick particles with an auto-generated template. Autopicked particles were manually inspected, then subjected to 2D classification in RELION (Scheres, 2012) specifying 100 classes. Poorly populated classes were removed, resulting in a dataset of 289,154 particles. These particles were individually aligned across movie frames and dose-weighted using direct-detector-align_lmbfgs software to generate "polished"
particles (Rubinstein and Brubaker, 2015) . A subset of the dataset was used to generate an initial model of the complex in cryoSPARC (ab-initio reconstruction).
"Polished" particles were 3D auto-refined in RELION using this ab-initio 3D template (low-pass filtered to 60 Å-resolution). RELION 3D classification into 2 classes was performed on the particles using the refined map and alignment angles. Among the 3D
classes, the best-resolved class, containing 87,657 particles, was 3D auto-refined and post-processed in RELION. The overall resolution of this class was 6.9Å (before postprocessing) and 5.2Å (after post-processing). Subsequent 3D classification did not improve resolution of this class.
Fdx/RbpA/σ A -holo. The same procedure as described above for Mtb RbpA/s A -holo was used. After RELION 2D classification, poorly populated classes were removed, resulting in a dataset of 63,839 particles. In the end, the best-resolved 3D class, containing 21,115 particles, was 3D auto-refined and post-processed in RELION. The overall resolution of this class was 8.1Å (before post-processing) and 6.5Å (after postprocessing).
Model building and refinement
To build initial models of the protein components of the complex, Msm RbpA/σ A -holo/usfork structure (PDB ID 5TWI) (Hubin et al., 2017a) was manually fit into the cryo-EM density maps using Chimera (Pettersen et al., 2004) and real-space refined using Phenix (Adams et al., 2010) . In the real-space refinement, domains of RNAP were rigidbody refined. For the high-resolution structures, the rigid-body refined models were subsequently refined with secondary structure restraints. A model of Fdx was generated from a crystal structure (Serra et al., 2017) , edited in Phenix REEL, and refined into the cryo-EM density. Refined models were inspected and modified in Coot (Emsley and Cowtan, 2004) according to cryo-EM maps, followed by further real-space refinement with PHENIX.
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The The boxed region is magnified on the right. Density for the RbpA NTT is outlined in red. (D) The core RNAP from the 3.3 Å resolution RbpA/RPo structure is shown as a gray molecular surface but with the closed clamp colored blue. The structure is sliced at the
